Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis of the GeparTrio trial data.
about
Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter A: Surgery, Pathology and Prognostic Factors, Adjuvant and Neoadjuvant Therapy, Adjuvant RadiotherapyLong-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes.Concurrent chemoradiotherapy for locally advanced breast cancer-time for a new paradigm?A Canadian national expert consensus on neoadjuvant therapy for breast cancer: linking practice to evidence and beyondNeoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments' armamentarium.Evaluation of clinical and pathological response after two cycles of neoadjuvant chemotherapy on Sudanese patients with locally advanced breast cancer.Weekly taxane-anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial.A systematic review of vinorelbine for the treatment of breast cancer.Management of locally advanced breast cancer-perspectives and future directions.Neoadjuvant clinical trials for the treatment of primary breast cancer: the experience of the German study groups.Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers.Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer.
P2860
Q30318610-02091CDC-13F7-473E-9B02-9705EFCFFD3FQ34392877-B8B1A02B-2414-43E5-B473-60933E8EFB0BQ35072438-19CE0779-7609-4992-985B-5ECE67D22592Q35239617-5E365CCD-A3FA-4D34-AB5E-03EB431B663FQ35667692-C961F39B-91BC-4EED-8DF6-62638D6FC2A8Q37594471-6A595722-A345-44DB-8668-08199E2D3E53Q37684270-C32A1257-8E59-4B1F-9F71-437FB44FAF9EQ38074206-B00CD18D-C627-4CDB-990C-BCFD48BA0856Q38350939-3EFEECF2-DD77-439A-9558-CF24B5F76AD4Q39664315-B02B0D29-2B50-4E8F-BC64-8A1CB04930BAQ42371602-A3E9C0F8-2CD5-4880-849A-C0615D0A59E2Q47156764-179F9AA0-3000-41FB-98CA-3018346178C1Q49166198-7ECF6E1E-C274-405A-AFAF-460ACD8543CA
P2860
Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis of the GeparTrio trial data.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Neoadjuvant chemotherapy shows ...... s of the GeparTrio trial data.
@ast
Neoadjuvant chemotherapy shows ...... s of the GeparTrio trial data.
@en
Neoadjuvant chemotherapy shows ...... s of the GeparTrio trial data.
@nl
type
label
Neoadjuvant chemotherapy shows ...... s of the GeparTrio trial data.
@ast
Neoadjuvant chemotherapy shows ...... s of the GeparTrio trial data.
@en
Neoadjuvant chemotherapy shows ...... s of the GeparTrio trial data.
@nl
prefLabel
Neoadjuvant chemotherapy shows ...... s of the GeparTrio trial data.
@ast
Neoadjuvant chemotherapy shows ...... s of the GeparTrio trial data.
@en
Neoadjuvant chemotherapy shows ...... s of the GeparTrio trial data.
@nl
P2093
P50
P356
P1476
Neoadjuvant chemotherapy shows ...... s of the GeparTrio trial data.
@en
P2093
Andreas du Bois
Bernd Gerber
Christian Jackisch
Christoph Thomssen
Dirk-Michael Zahm
Erich Weiss
Georg Peter Breitbach
Hans Tesch
Jens-Uwe Blohmer
Jörn Hilfrich
P356
10.1200/JCO.2009.23.5101
P407
P577
2009-11-09T00:00:00Z